Testosterone Treatment of Cardiovascular Diseases

1. Front Matter

   Pages I-IX

   PDF

2. Historical Review

   • Jens Møller, H. Einfeldt

   Pages 1-3

3. Significance of Cardiovascular Disease (CVD)

   • Jens Møller, H. Einfeldt

   Pages 4-5

4. Establishment of EOCCD

   • Jens Møller, H. Einfeldt

   Pages 6-6

5. Effectiveness of Testosterone Treatment

   • Jens Møller, H. Einfeldt

   Pages 7-9

6. Nature of CVD

   • Jens Møller, H. Einfeldt

   Pages 10-13

7. Factors Affecting the Heart and Blood Circulation

   • Jens Møller, H. Einfeldt

   Pages 14-27

8. Issue of Clinical Trials

   • Jens Møller, H. Einfeldt

   Pages 28-32

9. Clinical Findings

   • Jens Møller, H. Einfeldt

   Pages 33-41

10. Other Findings

    • Jens Møller, H. Einfeldt

    Pages 42-46

11. Prophylaxis

    • Jens Møller, H. Einfeldt

    Pages 47-48

12. Medical Treatment

    • Jens Møller, H. Einfeldt

    Pages 49-50

13. Testosterone and Plasma Lipids

    • Jens Møller, H. Einfeldt

    Pages 51-52

14. Parameters of CVD

    • Jens Møller, H. Einfeldt

    Pages 53-53

15. Conclusion

    • Jens Møller, H. Einfeldt

    Pages 54-55

16. Back Matter

    Pages 56-84

    PDF

For many years now I have devoted much of my time to lecturing and writing on the subject of cardiovascular disease (CVD). In this book I have outlined the development of my approach to this problem. I must admit that the details of my theories have undergone continuous modification as a result of the lessons learned in treating a large number of patients, but the basic message has remained the same. I believe that the delay in the utilization oftestosterone treatment for CVD has arisen from a failure by specialists in endocrinology, biochemistry, physi­ ology, and cardiology to understand each other's point of view and therefore to effectively coordinate their clinical efforts. This is like four people starting to climb the various faces of a pyramid, unaware of each other's presence until they reach the apex. It is hoped that bringing specialists in these different disciplines together at "summit meetings" will help them discover the true nature of this disease, the cardiovascular specialist understanding the underlying lack of anabolic steroids, and the other three grasping the way in which treatment with these compounds can effectively counteract the metabolic disturbance which is the cause of CVD. Even apart of the language barrier, writing this book has by no means been an easy task. Please consider my situation; one cannot be a cardiologist, endocrinologist, biologist, biochemist, and physiologist all in one person. This fact may open me to criticism.

• cardiology
• cardiovascular
• endocrinology
• heart disease
• steroid
• steroids
• vascular disease

• European Organization for the Control of Circulatory Diseases (EOCCD), Store Kongensgade 36, Copenhagen K, Denmark

  Jens Møller

• Krankenhaus St. Georg, Hamburg 1, Germany

  H. Einfeldt

Policies and ethics